Drug
Rmc 5552
Rmc 5552: highest development phase Phase 1, developed by Revolution Medicines, United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Revolution Medicines, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| RMC-5552 NCT04774952 | Phase 1 | Solid Tumors |
| RMC-5552 NCT05557292 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow Rmc 5552 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.